News + Filings Transactions
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
|
Touchon Pascal
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
08/18/2023 |
4
| Touchon Pascal (President and CEO) has filed a Form 4 on Atara Biotherapeutics, Inc.
Txns:
| Sold 21,432 shares
@ $1.652, valued at
$35.4k
Sold 9,334 shares
@ $1.653, valued at
$15.4k
|
|
06/29/2023 |
4
| Touchon Pascal (President and CEO) has filed a Form 4 on Atara Biotherapeutics, Inc.
Txns:
| Sold 14,291 shares
@ $1.66, valued at
$23.7k
|
|
05/18/2023 |
4
| Touchon Pascal (President and CEO) has filed a Form 4 on Atara Biotherapeutics, Inc.
Txns:
| Sold 29,766 shares
@ $2.037, valued at
$60.6k
|
|
03/06/2023 |
4
| Touchon Pascal (President and CEO) has filed a Form 4 on Atara Biotherapeutics, Inc.
Txns:
| Sold 15,679 shares
@ $3.627, valued at
$56.9k
|
|
11/18/2022 |
4
| Touchon Pascal (President and CEO) has filed a Form 4 on Atara Biotherapeutics, Inc.
Txns:
| Sold 15,591 shares
@ $4.49, valued at
$70k
|
|
08/18/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/29/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
05/19/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
03/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
11/18/2021 |
4
| Touchon Pascal (President and CEO) has filed a Form 4 on Atara Biotherapeutics, Inc.
Txns:
| Sold 8,402 shares
@ $17.1169, valued at
$143.8k
|
|
08/19/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/29/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
05/20/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
03/04/2021 |
4
| Touchon Pascal (President and CEO) has filed a Form 4 on Atara Biotherapeutics, Inc.
Txns:
| Sold 4,887 shares
@ $16.74, valued at
$81.8k
|
|
03/03/2021 |
4
| Touchon Pascal (President and CEO) has filed a Form 4 on Atara Biotherapeutics, Inc.
Txns:
| Granted 117,187 shares
@ $0 Granted 176,886 options to buy
@ $17.105, valued at
$3M
|
|
11/18/2020 |
4
| Touchon Pascal (President and CEO) has filed a Form 4 on Atara Biotherapeutics, Inc.
Txns:
| Sold 4,716 shares
@ $19.774, valued at
$93.3k
|
|
08/20/2020 |
4
| Touchon Pascal (President and CEO) has filed a Form 4 on Atara Biotherapeutics, Inc.
Txns:
| Sold 4,807 shares
@ $12.09, valued at
$58.1k
|
|
06/26/2020 |
4
| Touchon Pascal (President and CEO) has filed a Form 4 on Atara Biotherapeutics, Inc.
Txns:
| Sold 12,135 shares
@ $12.92, valued at
$156.8k
|
|
05/20/2020 |
4
| Touchon Pascal (President and CEO) has filed a Form 4 on Atara Biotherapeutics, Inc.
Txns:
| Sold 3,195 shares
@ $11.22, valued at
$35.8k
|
|
03/03/2020 |
4
| Touchon Pascal (President and CEO) has filed a Form 4 on Atara Biotherapeutics, Inc.
Txns:
| Granted 150,000 shares
@ $0 Granted 242,000 options to buy
@ $12.15, valued at
$2.9M
|
|
01/28/2020 |
4
| Touchon Pascal (President and CEO) has filed a Form 4 on Atara Biotherapeutics, Inc.
Txns:
| Paid exercise price by delivering 9,900 shares
@ $13.62, valued at
$134.8k
|
|
|
|